Evidence map›Paper›PMID 40047999›Full record

ArticleSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2025

Perturbations in the neuroactive ligand-receptor interaction and renin angiotensin system pathways are associated with cancer-related cognitive impairment.

Raymond J Chan, Adam Walker, Janette Vardy, Alexandre Chan, Kate Oppegaard, Yvette P Conley, Steven M Paul, Kord M Kober, Carolyn Harris, Joosun Shin and 6 more

Abstract read
In one paragraph

Article in Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Unraveling the impact ofBrain communications · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Raymond J ChanFlinders University, Bedford Park, Adelaide, South Australia, Australia.
Adam WalkerSchool of Clinical Medicine, University of New South Wales, Sydney, Australia.
Janette VardyFaculty of Medicine and Health, University of Sydney, Sydney, Australia.
Alexandre ChanSchool of Pharmacy and Pharmaceutical Sciences, University of California, Irvine, CA, USA.
Kate OppegaardVA Portland Health Care System, Portland, OR, USA.
Yvette P ConleySchool of Nursing, University of Pittsburgh, Pittsburgh, PA, USA.
Steven M PaulSchool of Nursing, University of California, San Francisco, CA, USA.
Kord M KoberSchool of Nursing, University of California, San Francisco, CA, USA.
Carolyn HarrisSchool of Nursing, University of Pittsburgh, Pittsburgh, PA, USA.
Joosun ShinDana Farber Cancer Institute, Boston, MA, USA.
Lisa MorseSchool of Nursing, University of California, San Francisco, CA, USA.
Ritu RoySchool of Medicine, University of California, San Francisco, CA, USA.
Adam OlshenSchool of Medicine, University of California, San Francisco, CA, USA.
Marilyn J HammerDana Farber Cancer Institute, Boston, MA, USA.
Jon D LevineSchool of Medicine, University of California, San Francisco, CA, USA.
Christine MiaskowskiSchool of Nursing, University of California, San Francisco, CA, USA. chris.miaskowski@ucsf.edu.

Funding

Symptoms Clusters in Oncology Patients Receiving ChemotherapyR01CA134900 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI AOUIZERAT, BRADLEY E, MIASKOWSKI, CHRISTINE A. · 2009 to 2014
$5.9M
An Investigation of the Molecular Mechanisms for and Prediction of the Severity of Cancer Chemotherapy-Related Fatigue Using a Multi-staged Integrated Omics ApproachR37CA233774 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KOBER, KORD MICHAEL · 2019 to 2025
$4.8M
Characterization of the Symptom Experience of Patients with Cutaneous Melanoma Receiving Immune Checkpoint Inhibitor TherapyR00CA286967 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Carolyn Stigge Harris · 2025 to 2026
$402k
Influence of Social Determinants of Health and Epigenomics on Psychological Symptom Cluster SeverityK99CA286967 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI HARRIS, CAROLYN STIGGE · 2024 to 2025
$323k
NCI NIH HHS CA082130NCI NIH HHS CA134900NCI NIH HHS CA233774NCI NIH HHS CA286967NCI NIH HHS K99 CA286967NCI NIH HHS R00 CA286967NCI NIH HHS R01 CA134900NCI NIH HHS R37 CA233774
6 · The paper itself

Abstract

purposeThis study reports on the results from our data-driven approach that identified perturbations in neuroactive ligand-receptor interaction and renin-angiotensin system (RAS) pathways in oncology patients with and without self-reported cancer-related cognitive impairment (CRCI).

methodsIn a sample of oncology patients receiving chemotherapy (n = 1343), the Attentional Function Index (AFI) was used to assess CRCI. Patients were grouped into low (AFI score of < 5) versus high (AFI score of > 7.5) levels of cognitive function. Gene expression analyses were done using RNA-seq (n = 185) and microarray (n = 158) technologies. Pathway impact analysis was used to evaluate for perturbations in biological pathways associated with self-reported CRCI.

resultsThe combined pathway impact analysis revealed that the neuroactive ligand-receptor interaction and RAS pathways were significantly perturbed between the patients with low versus high AFI scores.

conclusionsFindings from this study suggest that in addition to inflammatory pathways, numerous mechanisms may contribute to the underlying mechanisms for the development and/or persistence of self-reported CRCI.

Indexed as

Cognitive DysfunctionNeoplasmsRenin-Angiotensin SystemAdultAgedAntineoplastic AgentsFemaleHumansLigandsMaleMiddle AgedSelf ReportAntineoplastic AgentsLigandsCancerChemotherapyCognitive dysfunctionCognitive impairmentNeuroinflammationRenin angiotensin system

Identifiers

PMID40047999
PMCPMC11885406

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.